Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
03/2003
03/27/2003WO2003024446A1 Oxidation stress inhibitor and method of measuring oxidation stress
03/27/2003WO2003024444A1 Combination of selected opioids with muscarine antagonists for treating urinary incontinence
03/27/2003WO2003024390A2 Hydroxyeicosenoic acid analogs
03/27/2003WO2002096358A3 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
03/27/2003WO2002094263A3 Caspase inhibitors and uses thereof
03/27/2003WO2002087496A3 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
03/27/2003WO2002062377A3 Combined use of factor vii polypeptides and factor viii polypeptides
03/27/2003WO2002055544A3 Fibrin binding polypeptides useful inter alia in medical imaging processes
03/27/2003WO2002053100A3 Pharmaceutical dosage form for oral administration of low molecular weight heparin
03/27/2003WO2002043806A3 In vivo delivery methods and compositions
03/27/2003WO2002029060A3 Hematopoietin receptors hpr1 and hpr2
03/27/2003WO2002026774A3 Melanocortin receptor ligands
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002005857A3 Phosphatonin-related gene and methods of use thereof
03/27/2003US20030060877 Coated medical devices for the treatment of vascular disease
03/27/2003US20030060873 Providing an electrochemical solution comprising metal and bioactive material; contacting electrochemical solution and substrate; forming a bioactive composite structure on substrate using an electrochemical procedure
03/27/2003US20030060619 Antibody for use in the disgnosis and treatment of kidney, urogenital, and sex disorders
03/27/2003US20030060506 Bile secretion promoting composition
03/27/2003US20030060487 Useful for treatments for peptide aggregation associated with disease state such as Alzhemimer's diseases
03/27/2003US20030060474 A piperazine compound as antithrombotic agent
03/27/2003US20030060466 Such as 6-(4-(4-Fluoro-phenyl)-piperazin-1-yl)-2-methyl-5-nitro-3-(2,2,2-trifluoro -ethyl)-3H-pyrimidin-4-one, which are metabotropic glutamate receptor antagonists useful in treating psychological disorders
03/27/2003US20030060449 Nutraceuticals for treatment of leukemia and solid tumors
03/27/2003US20030060411 A mixture of active blood-coagulation Factor VII and Factor X for treating hemorrhage blood disorders
03/27/2003US20030060410 Use of HMG fragments as anti-inflammatory agents
03/27/2003US20030059871 Hematopoietin receptors HPR1 and HPR2
03/27/2003US20030059862 Antibodies against tumor necrosis factor delta (APRIL)
03/27/2003US20030059852 Detecting modulators of integrin activity; obtain sample containing integrin, incubate with test compound, monitor adjustment in integrin activity, adjustment in integrin activity indicates modulator
03/27/2003US20030059767 Zinc finger protein derivatives and methods therefor
03/27/2003US20030059479 A cell activating agent comprising a royal jelly and alpha, alpha- trehalose which acts as a stabilizer and preservative at low temperatures; tonic, health food or health supplement; cosmetics
03/27/2003US20030059427 Isolation and characterization of highly active anti-CD40 antibody
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030058245 Method and apparatus for computer modeling diabetes
03/27/2003CA2461073A1 6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2461072A1 Compounds which inhibit the release of inflammatory cytokines
03/27/2003CA2461071A1 Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460358A1 Hydroxyfattysulfonic acid analogs
03/27/2003CA2460263A1 Hydroxyeicosenoic acid analogs
03/27/2003CA2459773A1 Enamel matrix protein compositions for modulating immune response
03/26/2003WO2002026978A1 Novel proteins, genes encoding them and method of using the same
03/26/2003WO2002026732A1 Benzodiazepine derivative
03/26/2003EP1295939A1 Insulin-like growth factor binding protein
03/26/2003EP1295126A2 Hepatitis c viral antigen immunoassay detection systems
03/26/2003EP1294904A1 Heterodimeric fusion proteins
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
03/26/2003EP1294767A1 Low oxygen affinity mutant hemoglobins
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294750A2 Acid-modified arabinogalactan protein composition
03/26/2003EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/26/2003EP1294741A2 Dipeptide inhibitors for the blood-clotting factor xa
03/26/2003EP1294728A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD
03/26/2003EP1294724A1 Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents
03/26/2003EP1294721A1 Cyclic gmp-specific phosphodiesterase inhibitors
03/26/2003EP1294716A1 Lactam inhibitors of factor xa and method
03/26/2003EP1294714A2 Thrombin receptor antagonists
03/26/2003EP1294711A2 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as as modulators of protein kinases
03/26/2003EP1294699A2 Modulators of tnf- alpha signalling
03/26/2003EP1294696A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
03/26/2003EP1294691A1 Serine protease inhibitors
03/26/2003EP1294689A1 Novel $g(b crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
03/26/2003EP1294681A2 Fmoc-l-leucine and derivatives thereof as ppar- gamma agonists
03/26/2003EP1294679A1 Beta-amino acid nitrile derivatives
03/26/2003EP1294395A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR
03/26/2003EP1294394A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR Xa INHIBITOR
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP1294390A2 The use of copolymer 1 and related peptides and polypeptides and t cells treated therewith for neuroprotective therapy
03/26/2003EP1294380A1 A method for treating septic shock
03/26/2003EP1294378A2 Thrombopoietin mimetics
03/26/2003EP1294376A2 Medicament for combating respiratory depression
03/26/2003EP1294356A2 Sustained release delivery systems for solutes
03/26/2003EP1105384B1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/26/2003EP1028717B1 Unsubstituted polydiallylamine for treating hypercholesterolemia
03/26/2003EP0994898B1 Integrin binding peptide and use thereof
03/26/2003EP0804418B1 Platelet aggregation inhibitors
03/26/2003EP0769962B1 Method of attenuating arterial stenosis
03/26/2003CN1406280A Progenitor cell preservation factors and related methods and products
03/26/2003CN1406245A Method of eliminating human serum albumin polymers
03/26/2003CN1406226A Novel malonic acid derivatives, process for their preparation, their use as inhibitor of factor XA activity and pharmaceutical compositions containing them
03/26/2003CN1406132A Method for treating or inhibiting cellular injury or cell death
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1404877A Blood-platelet specific mosaic immune globulin and its using method
03/26/2003CN1404872A Method for producing antithrombotic medicine by using silk-worm
03/26/2003CN1103815C Thrombin mutants
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CN1103606C Bi papcitide-based pharmaceutical compositions for imaging and treating thrombi
03/26/2003CN1103594C Application of injection for treating thrombocyto penic purpura
03/26/2003CA2423902A1 Benzodiazepine derivative
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/26/2003CA2405378A1 Stable taurolidine electrolyte solutions
03/25/2003US6538116 For therapy of inflammatory or painful disorder
03/25/2003US6538017 Anticoagulants; cardiovascular disorders; central nervous system disorders
03/25/2003US6538013 Acyclic and cyclic guanidine-and acetamidine derivatives, their preparation and their use as pesticides, esp. as parasiticides
03/25/2003US6538009 Pyrazole derivatives as anti-inflammatory/analgesic agents
03/25/2003US6538007 Hydrates and method of antogonizing glycoprotein IIb/IIIa activity using these compounds is also disclosed. antagonist, inhibitor of blood platelets aggregation and inhibitor of the binding of fibrinogen to blood platelets.
03/25/2003US6537588 Food-induced antisecretory proteins in egg yolk
03/25/2003CA2125783C Methods for producing thrombin
03/25/2003CA2065496C Treatment of aphthous ulcers and other mucocutaneous disorders
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023014A2 Human ion channels
1 ... 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 ... 671